Institutional Investors May Overlook Nuvation Bio Inc.'s (NYSE:NUVB) Recent US$54m Market Cap Drop as Long-term Gains Remain Positive

Simply Wall St01/01 22:04

Why Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now?

Yahoo Finance2024/12/31 04:00

Sector Update: Health Care Stocks Fall Premarket Monday

MT Newswires2024/12/23 22:21

Nuvation Bio Announces The U.S. FDA Accepts For Priority Review Nuvation Bio's New Drug Application For Taletrectinib For The Treatment Of Advanced ROS1-Positive Non-Small Cell Lung Cancer

Benzinga2024/12/23 21:05

Clear Street Launches Healthcare & Biotechnology Equity Research

Businesswire2024/12/18 03:00

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference

Businesswire2024/11/26 21:00